Lumos secures new contract manufacturing agreement
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Lumos Diagnostics Holdings Ltd. has announced a new contract manufacturing agreement with Micro-Pak for the production of the Mold Analyzer system, which allows for rapid mold detection. The agreement includes the first purchase order valued at a significant amount, marking the start of commercial-scale manufacturing for Micro-Pak. This contract builds on previous development work and is set for three years with automatic renewal options. Lumos CEO Doug Ward emphasized the importance of this agreement in validating Lumos' services and supporting Micro-Pak's commercial success.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos receives largest FebriDx order to date
- Investor Presentation
- Lumos completes $20m placement and launches SPP
- US FDA Grants CLIA Waiver for FebriDx
- Trading Halt
Later from Lumos Diagnostics
- Prospectus
- Response to ASX Aware Letter
- FebriDx Paediatric Study Enrolment Milestone Achieved
- FebriDx U.S. Rollout and Reimbursement Update
- FebriDx U.S. Rollout and Reimbursement Update - Amended
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics